Australia markets closed

AFT Pharmaceuticals Limited (AFP.AX)

ASX - ASX Delayed price. Currency in AUD
Add to watchlist
3.35000.0000 (0.00%)
At close: 01:54PM AEDT
Currency in AUD

Valuation measures4

Market cap (intra-day) 355.79M
Enterprise value 385.50M
Trailing P/E 22.42
Forward P/E 16.92
PEG ratio (5-yr expected) N/A
Price/sales (ttm)2.75
Price/book (mrq)6.59
Enterprise value/revenue 2.75
Enterprise value/EBITDA 19.27

Trading information

Stock price history

Beta (5Y monthly) 0.28
52-week change 3-14.54%
S&P500 52-week change 3-7.13%
52-week high 33.9200
52-week low 32.9000
50-day moving average 33.4000
200-day moving average 33.2769

Share statistics

Avg vol (3-month) 3728
Avg vol (10-day) 3108
Shares outstanding 5104.87M
Implied shares outstanding 6N/A
Float 827.53M
% held by insiders 173.82%
% held by institutions 15.62%
Shares short 4N/A
Short ratio 4N/A
Short % of float 4N/A
Short % of shares outstanding 4N/A
Shares short (prior month ) 4N/A

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 30.00
Trailing annual dividend yield 30.00%
5-year average dividend yield 4N/A
Payout ratio 40.00%
Dividend date 3N/A
Ex-dividend date 4N/A
Last split factor 2N/A
Last split date 3N/A

Financial highlights

Currency in NZD.

Fiscal year

Fiscal year ends 31 Mar 2022
Most-recent quarter (mrq)30 Sept 2022


Profit margin 12.14%
Operating margin (ttm)13.06%

Management effectiveness

Return on assets (ttm)9.89%
Return on equity (ttm)34.28%

Income statement

Revenue (ttm)140.55M
Revenue per share (ttm)1.13
Quarterly revenue growth (yoy)18.40%
Gross profit (ttm)61.77M
Net income avi to common (ttm)17.06M
Diluted EPS (ttm)0.1500
Quarterly earnings growth (yoy)-65.80%

Balance sheet

Total cash (mrq)8.79M
Total cash per share (mrq)0.08
Total debt (mrq)41.31M
Total debt/equity (mrq)70.70
Current ratio (mrq)1.28
Book value per share (mrq)0.56

Cash flow statement

Operating cash flow (ttm)13.31M
Levered free cash flow (ttm)-347.88k